Category: Diseases & Conditions
Diseases & Conditions market research reports by GlobalData
-
Ewing Sarcoma - Global Clinical Trials Review, 2024
Ewing Sarcoma - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, 2024 provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Re ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024 provides an overview of Cutaneous Squamous Cell Carcinoma (cSCC) Clinical trials scenario. This r ... Read More
-
Seasonal Influenza - Global Clinical Trials Review, 2024
Seasonal Influenza - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Seasonal Influenza - Global Clinical Trials Review, 2024 provides an overview of Seasonal Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Se ... Read More
-
Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024
Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024 provides an overview of Hemophilia A (Factor VIII Deficiency) Clinical trials scenario. This report pro ... Read More
-
Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032
Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032 Summary Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases (National Cancer Institute, 2020). NSCLC begins when healthy cells that make up the lining of ... Read More
-
Ovarian Cancer Opportunity Assessment and Forecast
Ovarian Cancer Opportunity Assessment and Forecast Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 7MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Ovarian Cancer. These sales fo ... Read More
-
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize qu ... Read More
-
Digital Marketing Trends in Psoriasis - January 2024
Digital Marketing Trends in Psoriasis - January 2024 Summary AbbVie’s Skyrizi.com achieved the highest total traffic across branded PsO patient sites in the US, with almost three million visitors from January 2023 to December 2023. This was followed by Amgen’s Otezla.com (1.7 million visits). Overal ... Read More
-
Malaria - Global Clinical Trials Review, 2024
Malaria - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Malaria - Global Clinical Trials Review, 2024 provides an overview of Malaria Clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes an overvie ... Read More
-
Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024
Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024 provides an overview of Lennox-Gastaut Syndrome Clinical trials scenario. This report provides top line data relating to the clinic ... Read More
-
Thematic Intelligence - Biosimilars in oncology
Thematic Intelligence - Biosimilars in oncology Summary Clients will gain insight into the percentage of cancer patients treated with biosimilars, the price of these agents compared to their originator, and key opinion leaders’ outlook for the products. The report includes the 8MM regulatory landsca ... Read More
-
Gout - Opportunity Assessment and Forecast
Gout - Opportunity Assessment and Forecast Summary The prevalence of gout is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 1.18%. Currently, the treatment regimen for gout in the 7MM is mostly limited to NSAIDs, corticosteroids, and ULTs with challenging safety ... Read More
-
Hepatitis B - Global Clinical Trials Review, 2023
Hepatitis B - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatitis B Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatitis B Clinical trials scenario. This report provides top line data ... Read More
-
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update pro ... Read More
-
Gallbladder Cancer - Global Clinical Trials Review, 2023
Gallbladder Cancer - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report pr ... Read More
-
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatocellular Carcinoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatocellular Carcinoma Clinical trials scenar ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Chronic ... Read More
-
Osteoporosis - Global Clinical Trials Review, 2023
Osteoporosis - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Osteoporosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Osteoporosis Clinical trials scenario. This report provides top line da ... Read More
-
Insomnia - Opportunity Assessment and Forecast
Insomnia - Opportunity Assessment and Forecast Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the insomnia market through 2032. Insomnia, currently represented in the International Classification of Sleep Disorders (Th ... Read More
-
Gaucher Disease - Opportunity Assessment and Forecast
Gaucher Disease - Opportunity Assessment and Forecast Summary The prevalence of GD is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 0.39%. Currently, the marketed treatment regimen for Type 1 GD and Type 3 GD is dominated by ERTs and SRTs (Cerezyme, VPRIV, Elel ... Read More
-
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regul ... Read More
-
Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulator ... Read More
-
Generalized Pustular Psoriasis (GPP) - Competitive Landscape
Generalized Pustular Psoriasis (GPP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in GPP therapeutics. More than 21,700 diagnosed prevalent cases of GPP are anticipated in 2023 in the 16 countries covered in GlobalData’s ... Read More
-
Anal Cancer (AC) - Competitive Landscape
Anal Cancer (AC) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AC therapeutics. More than 33,000 diagnosed incident cases of AC are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast ... Read More
-
Aromatherapy Market - By Product (Consumables, Equipment), Mode of Delivery (Topical, Aerial Diffusion, Direct Inhalation), Application (Mental Health, Pain, Scar Management), End-use - Global Forecast 2023-2032
Aromatherapy Market - By Product (Consumables, Equipment), Mode of Delivery (Topical, Aerial Diffusion, Direct Inhalation), Application (Mental Health, Pain, Scar Management), End-use - Global Forecast 2023-2032 Aromatherapy market size is predicted to witness 10.9% CAGR from 2024 to 2032 due to the ... Read More
Research Assistance
